YESAFILI
- Product NDC
- 83257-013
- Requested package NDC
- 83257-013-01
- 11-digit product format
- 832570013
- Labeler code
- 83257
- Product ID
- 83257-013_a1870a7c-4e43-7841-0770-f4f8d9a5d0bf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- aflibercept-jbvf
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Labeler
- Biocon Biologics Inc.
- Application
- BLA761274
- Marketing category
- BLA
- Marketing start
- 2026-11-03
- Substance
- AFLIBERCEPT
- Active strength
- 2 mg/.05mL
- Pharmacologic classes
- Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- YESAFILI
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| AFLIBERCEPT | 2 mg/.05mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 15C2VL427D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7d69a7b0-9511-c030-3b85-13b23f9d2980 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| YESAFILI | AFLIBERCEPT-JBVF | Biocon Biologics Inc. | 7d69a7b0-9511-c030-3b85-13b23f9d2980 | 2026-07-28 | Warnings, Adverse reactions | BLA761274 83257-013-01 83257-013 83257001301 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761274 | Yesafili | aflibercept-jbvf | 351(k) Interchangeable | Rx | 2026-10-01 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 83257-013-01 | 83257001301 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83257-013-01) / .05 mL in 1 VIAL, SINGLE-DOSE | 2026-11-03 | No | No | Current |